{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:30:00Z","timestamp":1740461400480,"version":"3.37.3"},"reference-count":15,"publisher":"Wiley","issue":"S672","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":9599,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[1983,1,12]]},"abstract":"<jats:p><jats:bold>ABSTRACT<\/jats:bold>Most \u03b2\u2010adrenergic effects are mediated by activation of the enzyme adenylate cyclase. Hormone binds to the receptor leading to an accelarated binding of GTP to the coupling protein, the N\u2010protein, which is activated. This causes an activation of the adenylate cyclase and an increased formation of cAMP, the intracellular second messenger. The same principles hold good for other hormones coupled to adenylate cyclase. The sensitivity of the adenylate cyclase may be altered in different clinical and experimental conditions. An increased sensitivity is seen in hyperthyroidism in man and in the rat, and during starvation in rats. A decreased sensitivity is seen in hypothyroidism, in patients with pheochromocytoma, pseudohypoparathyroidism type I or multiple symmetric lipomatosis. Several reasons for the altered sensitivity have been suggested. The number of hormone receptors, the coupling between receptor and N\u2010protein, the amount or function of the N\u2010protein or the PDE activity may all vary in different conditions.<\/jats:p>","DOI":"10.1111\/j.0954-6820.1983.tb01608.x","type":"journal-article","created":{"date-parts":[[2010,8,15]],"date-time":"2010-08-15T11:01:18Z","timestamp":1281870078000},"page":"17-20","source":"Crossref","is-referenced-by-count":4,"title":["Coupling between the \u03b2\u2010adrenergic receptor and the adenylate cyclase \u2013 pathophysiological implications"],"prefix":"10.1111","volume":"213","author":[{"given":"Christian","family":"Wesslau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0021-9258(19)86136-7","article-title":"Inhibition of magnesium uptake by beta\u2010adrenergic agonists and prostaglandin E1 is not mediated by cyclic AMP.","volume":"255","author":"Maguire ME","year":"1980","journal-title":"J Biol Chem"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0026-895X(25)14062-5","article-title":"A quantitative analysis of beta\u2010adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data.","volume":"17","author":"Kent RS","year":"1980","journal-title":"Mol Pharmacol"},{"key":"e_1_2_1_4_2","first-page":"309","article-title":"GTP\u2010dependent stimulation and inhibition of adenylate cyclase.","volume":"6","author":"Cooper DMF","year":"1982","journal-title":"Horiz Biochem Biophys"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1980.tb00043.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1981.tb05154.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(81)91573-4"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-48-3-415"},{"key":"e_1_2_1_9_2","first-page":"424","article-title":"\u03b2\u2010adrenergic receptors in human fat cells \u2010 characterization and studies in altered thyroid states.","volume":"12","author":"Jacobsson B","year":"1981","journal-title":"Adv Cycl Nucl Res"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1972.tb04830.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0021-9258(17)38155-3","article-title":"Fat cell adenylate cyclase and beta\u2010adrenergic receptors in altered thyroid states.","volume":"253","author":"Malbon CC","year":"1978","journal-title":"J Biol Chem"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/S0021-9258(17)40528-X","article-title":"Thyroid hormone regulation of beta\u2010adrenergic receptor number.","volume":"252","author":"Williams LT","year":"1977","journal-title":"J Biol Chem"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110397"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198007313030501"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108881"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1977.tb01620.x"}],"container-title":["Acta Medica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0954-6820.1983.tb01608.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0954-6820.1983.tb01608.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T14:56:03Z","timestamp":1740408963000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0954-6820.1983.tb01608.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,1,12]]},"references-count":15,"journal-issue":{"issue":"S672","published-print":{"date-parts":[[1983,1,12]]}},"alternative-id":["10.1111\/j.0954-6820.1983.tb01608.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0954-6820.1983.tb01608.x","archive":["Portico"],"relation":{},"ISSN":["0001-6101"],"issn-type":[{"type":"print","value":"0001-6101"}],"subject":[],"published":{"date-parts":[[1983,1,12]]}}}